Skip to main content
TOPICS
Videos
Provider
Payer
Pharma
Consumer
Investor
RESOURCES
Events
Jobs
Learning Center
Webinars
White Papers
REGIONS
ANZ
ASIA
EMEA
Global Edition
MORE
About
Advertise
Contact
Privacy Policy
ANZ
ASIA
EMEA
Global Edition
CytoCare
AI drug discovery platform CytoReason enters Japan via partnership with Sumitomo's SPI
By
Adam Ang
|
05:03 am |
September 30, 2021
This collaboration will work with an unnamed pharma company in Japan to know how its drugs behave compared to rival products.
